Lantern Pharma CEO to Present at the Benzinga Healthcare Small Cap Conference on September 29th

PR Newswire

DALLAS, Sept. 22, 2021 /PRNewswire/ — Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“A.I.”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, today announced that Panna Sharma, President & CEO of Lantern Pharma will present at the Benzinga Healthcare Small Cap Conference, which is being held virtually from September 29 – 30, 2021.

Mr. Sharma will deliver his corporate presentation on Wednesday, September 29th at 11:55 AM ET and will also be available for one-on-one meetings throughout the conference.

Investors can register for the conference here: https://www.benzinga.com/events/small-cap/healthcare/.

About Lantern Pharma

Lantern Pharma (LTRN) is a clinical-stage oncology-focused biopharmaceutical company leveraging its proprietary RADR® A.I. platform and machine learning to discover biomarker signatures that identify patients most likely to respond to its pipeline of genomically targeted therapeutics. Lantern is currently developing four drug candidates and an ADC program across eight disclosed tumor targets, including two phase 2 programs. By targeting drugs to patients whose genomic profile identifies them as having the highest probability of benefiting from the drug, Lantern’s approach represents the potential to deliver best-in-class outcomes. More information is available at: www.lanternpharma.com and Twitter @lanternpharma.

CONTACTS:

Investor Relations

David Waldman, Crescendo Communications, LLC
[email protected]
212-671-1021

Public Relations

Nicholas Koulermos, Vice President – 5W Public Relations
[email protected]
646-843-1812

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lantern-pharma-ceo-to-present-at-the-benzinga-healthcare-small-cap-conference-on-september-29th-301382827.html

SOURCE Lantern Pharma

Amgen Releases 8th Edition of Biosimilar Trends Report

Report Finds That Competition Created by Biosimilars Delivered $9.8 Billion in Savings Over the Past Five Years to the U.S. Healthcare System, Generating Savings for Patients, Payers and Employers

With Both a Strong Innovator Portfolio and a Deep Investment in Biosimilar Products, Amgen has Been a Pioneer in Biotechnology for ~40 Years and Invested Close to $2 Billion Across a Portfolio of 10 Biosimilar Medicines

PR Newswire

THOUSAND OAKS, Calif., Sept. 22, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today released the 8th edition of the Biosimilar Trends Report, which examines the current state of the U.S. biosimilars marketplace across inflammation, oncology and nephrology categories, while a new feature considers how advancements in biosimilars can support the long-term success and sustainability of the U.S. healthcare system. To access the full report, visit: www.amgenbiosimilars.com/commitment/trends-report.

To view the multimedia assets associated with this release, please click: https://www.multivu.com/players/English/8812854-amgen-8th-edition-biosimilar-trends-report/  

2021 Biosimilar Trends Report One-pager

The Report shows that competition created by biosimilars has saved the U.S. healthcare system $9.8 billion over the past five years,i and has the potential to reduce out-of-pocket spending by $238 million for patients in the nine biologic drug classes where biosimilars have been approved. According to the Report:

  • Biosimilars contribute to competition that drives down healthcare costs by providing significant wholesale acquisition cost (WAC) and average sales price (ASP) discounts at launch, resulting in additional savings over time.
  • Biosimilars are launching at a price that is generally 15% to 37% lower than the reference product.ii Furthermore, the ASP is declining for both reference products and biosimilars over time, while the rate of biosimilar uptake is generally increasing over time.iii,iv
  • Biosimilars have gained substantial share in the majority of therapeutic areas where they have been introduced.v For therapeutic areas with biosimilars launched in the last two years, the average share was 65%.vi

This year’s Report features a new section, Future State of the Marketplace, which outlines how biosimilars can continue to offer more affordable treatment options, drive cost savings through increased competition between biosimilars and with reference biologics, and promote a more resilient U.S. healthcare marketplace. The U.S. marketplace is poised to see further growth in biosimilars approved to date and welcome many new biosimilars in the years to come.

“As part of Amgen’s commitment to staying at the forefront of biosimilar education, Amgen is pleased to announce the launch of the 2021 Biosimilar Trends Report,” said Jennifer Norton, vice president, Head of U.S. Value and Access at Amgen. “The increasing availability and adoption of biosimilars means these treatments are delivering on the fundamental promise of reducing healthcare costs for payers, employers, and patients in the United States.”

The 2021 Biosimilar Trends Report also outlines the four key elements that Amgen believes are necessary for sustaining biosimilars’ growth:

  • Implementing scientifically appropriate regulatory standards for the approval, manufacture, and uninterrupted availability of safe and effective biological products, including biosimilars;
  • Maintaining a marketplace that encourages competition on a level playing field to achieve meaningful savings and long-term stability;
  • Providing scientifically accurate educational outreach to drive confidence with healthcare providers, patients, payers, and employers; and
  • Ensuring a foundation of strong intellectual property to encourage innovation and investment.

“The U.S. marketplace with biosimilars is well established and accelerating across key therapeutic areas, creating cost savings, and additional treatment options for physicians and patients,” said Chad Pettit, executive director, Marketing, Global Biosimilars Commercial Lead at Amgen, adding, “By continuing to advance science-based policies that support competition and enhance confidence from patients, physicians, and other stakeholders, the U.S. can help promote a robust and resilient healthcare system needed for the long term.”

About Amgen Biosimilars
Amgen is committed to building upon Amgen’s experience in the development and manufacturing of innovative human therapeutics to expand Amgen’s reach to patients with serious illnesses. Biosimilars help to maintain Amgen’s commitment to connect patients with vital medicines, and Amgen is well positioned to leverage its nearly four decades of experience in biotechnology to create high-quality biosimilars and reliably supply them to patients worldwide.

For more information, visit www.amgenbiosimilars.com and follow us on www.twitter.com/amgenbiosim.

About Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.  

CONTACT: Amgen, Thousand Oaks 
Megan Fox, 805-447-1423 (media)
Trish Rowland, 805-447-5631(media) 
Arvind Sood, 805-447-1060 (investors) 

i Data on file, Amgen; Biosimilars Spend Analysis; July 2021.
ii Data on file, Amgen; Product and Biosimilars – WAC and ASP Price; July 2021.
iii Data on file, Amgen; Product and Biosimilars – WAC and ASP Price; July 2021
iv Data on file, Amgen; Biosimilars Market Share Trends; July 2021
v Data on file, Amgen; Biosimilars Market Share Trends; July 2021
vi Data on file, Amgen; Biosimilars Market Share Trends; July 2021

The Promise of Biosimilars Factsheet

 

Cision View original content:https://www.prnewswire.com/news-releases/amgen-releases-8th-edition-of-biosimilar-trends-report-301382173.html

SOURCE Amgen

Goodyear Opts For Renewable Energy In European And Turkish Plants

Decision strengthens company goal of reducing carbon emissions intensity by 25% by 2023

Shift will reduce the company’s carbon footprint by up to 260,000 tons

PR Newswire

BRUSSELS, Sept. 22, 2021 /PRNewswire/ — The Goodyear Tire & Rubber Company (NASDAQ: GT) today announced it will adopt 100% renewable energy at its Goodyear plants across Europe and Turkey* in the first of a multiple-phase plan to procure 100% renewable energy in all its facilities across Europe, Middle East and Africa by the end of 2022.

The decision, made in conjunction with the company’s development of its long-term climate strategy, will enable Goodyear to reduce operational impacts and aligns with its goal of reducing carbon emissions intensity by 25% by 2023 versus a 2010 baseline. The company already achieved 19% intensity reduction in 2020 as reported in its latest Corporate Responsibility Report.

By purchasing around 700,000 megawatt-hours of renewable electricity, Goodyear can ensure that manufacturing plants in France, Germany, Luxembourg, Poland, Slovenia, Turkey and the Netherlands will operate on sustainably sourced electricity. This shift will reduce the company’s carbon footprint by up to 260,000 tons.

Goodyear will increase usage of renewable energy sources like hydro, wind, solar or geothermic biomass power to achieve this critical shift. To ensure electricity has been produced from renewable energy sources, Goodyear procures GoOs (Guarantee of Origin), which provide information to electricity customers on the source of their energy.

“Switching to 100% renewable electricity at these production facilities fits perfectly with our commitment to reduce our carbon footprint,” said Chris Delaney, president, Goodyear EMEA. “Furthermore, this decision shows that we are taking serious steps to continuously reduce Goodyear’s environmental impacts which is vitally important to ensure a better future for us all.”

This is one of a number of actions Goodyear is taking to ensure it contributes to a reduction in carbon emissions. Earlier this year the company announced it would construct Luxembourg’s first large scale solar carport which is now operational.

* France, Germany, Luxembourg, Poland, Slovenia, Turkey, and the Netherlands will be included in the first phase, other Goodyear locations such as Goodyear in South Africa, and Cooper Tire plants in Serbia and UK will be reviewed in a second phase.



About The Goodyear Tire & Rubber Company

Goodyear is one of the world’s largest tire companies. It employs about 72,000 people and manufactures its products in 55 facilities in 23 countries around the world. Its two Innovation Centers in Akron, Ohio, and Colmar-Berg, Luxembourg, strive to develop state-of-the-art products and services that set the technology and performance standard for the industry. For more information about Goodyear and its products, go to www.goodyear.com/corporate.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/goodyear-opts-for-renewable-energy-in-european-and-turkish-plants-301382512.html

SOURCE The Goodyear Tire & Rubber Company

Celebrate National Coffee Day with Dutch Bros for a chance to win Dutch for a Year

100 lucky Dutch Rewards members will win

PR Newswire

GRANTS PASS, Ore., Sept. 22, 2021 /PRNewswire/ — Dutch Bros Coffee, is celebrating National Coffee Day by kicking off Dutch for a Year where 100 winners will win a free drink every day for a whole year!

Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8835856-dutch-bros-coffee-national-coffee-day-win-dutch-for-a-year/

Customers get a chance to instantly win when they use the Dutch Bros app to make a purchase or redeem a reward at the window (limit one chance per day). Winners will receive a free drink every day for a whole year!

“Our customers are the absolute best and we’re so stoked to give them a chance to get their daily fix for free,” said Ashley Smith, lead broista. “Make sure to show your broista your Dutch Pass the next time you roll through!”

Customers can order and enjoy specialty coffee, smoothies, freezes, teas, exclusive Dutch Bros Blue Rebel energy drinks and nitrogen-infused cold brew coffee. All drinks are handcrafted for each customer and guaranteed to satisfy.

“The best part of the Dutch Bros app is that we really tried to insert our culture,” said Kristen Flemington, Senior Director of Digital Marketing. “We don’t want to take away from the Dutch Bros experience so we built in features that would enhance it.”

The app allows members to pay contact-free, earn points and score rewards! The Dutch for a Year promotion lasts through October 31 or until 100 winners have been selected, whichever comes first. See official rules here. The Dutch Bros app is available on the App Store and Google Play.


About Dutch Bros

Dutch Bros Coffee is a drive-thru coffee company dedicated to making a massive difference one cup at a time. Headquartered in Grants Pass, Oregon, where it was founded in 1992 by Dane and Travis Boersma, it’s now sharing the “Dutch Luv” with more than 500 locations in 11 states. Dutch Bros serves specialty coffee, smoothies, freezes, teas, an exclusive Dutch Bros’ Blue Rebel energy drink and nitrogen-infused cold brew coffee. Its rich, proprietary coffee blend is handcrafted from start to finish.

In addition to its mission of speed, quality and service, Dutch Bros is committed to giving back to the communities it serves. Through its Dutch Bros Foundation and local franchisees, the company donates several million dollars to causes across the country each year.

To learn more about Dutch Bros, visit www.dutchbros.com, follow Dutch Bros Coffee on Instagram, Facebook, Twitter, & TikTok, and download the Dutch Bros app to earn points and score rewards!

100 Dutch Bros customers will win one Dutch drink per day for a year. The Dutch Bros app is the easiest way to enter.

 

100 Dutch Bros customers will win one Dutch drink per day for a year. The Dutch Bros app is the easiest way to enter.

 

Logo_Dutch_Bros_Coffee_Logo

 

Cision View original content:https://www.prnewswire.com/news-releases/celebrate-national-coffee-day-with-dutch-bros-for-a-chance-to-win-dutch-for-a-year-301382767.html

SOURCE Dutch Bros Coffee

Invesco ETFs and Galaxy Digital Partner to Offer Investors Exposure to an Expansive Range of Products in the Digital Asset Ecosystem

New partnership combines the best-in-class expertise of both firms to bring clients an array of new U.S.-listed investment opportunities in the digital asset space

PR Newswire

ATLANTA and NEW YORK, Sept. 22, 2021 /PRNewswire/ — Galaxy Digital Holdings Ltd. (TSX: GLXY)1 (“Galaxy Digital”) a leading financial services innovator in the digital asset, cryptocurrency, and blockchain technology sectors, and Invesco Ltd. (NYSE: IVZ), a leading global asset management firm, announced today a strategic partnership to develop a comprehensive suite of U.S.-listed, physically backed, digital asset exchange traded funds (“ETFs”). This alliance of market-leading capabilities will offer investors an unprecedented combination of solutions and information that give structure to the complex and fast-moving digital assets space.

“Invesco has a long history of using ETFs to democratize investor access to disruptive, innovative asset classes. Now, through our partnership with market leader Galaxy Digital, we are able to incorporate their expertise of blockchain technology, digital assets and cryptocurrency into our product capabilities,” said John Hoffman, Head of Americas, ETFs & Indexed Strategies at Invesco. “This combination of complementary strengths will help clients safely and prudently navigate this exciting new asset class to help meet their desired investment outcomes.”

“Galaxy Digital is laser-focused on helping investors safely and efficiently access this burgeoning asset class,” added Steve Kurz, Head of Asset Management at Galaxy Digital. “Our partnership with Invesco, a longstanding ETF innovator, will bring the same thoughtful approach to educating investors about digital assets as Invesco has brought to the ETF industry itself.”

In the last three years, Invesco ETFs & Indexed Strategies has more than doubled its assets under management (“AUM”) to $471 billion USD2 globally by both launching new ETFs and elevating existing products that help solve specific client needs. 

Galaxy Digital has $2.1 billion USD in AUM3. Its asset management business is rapidly expanding its capabilities to provide institutional-grade exposure to every investable corner of the crypto and blockchain ecosystems. As a first mover and leader in digital asset and blockchain funds, the asset management team combines extensive experience at both top-tier financial institutions and within the digital asset sector, working closely with bank platforms, institutional investors, and asset managers across distribution, client service, operations, and portfolio management.

1 Galaxy Digital Holdings Ltd. is not affiliated with Invesco.
2Source, Invesco Finance, as of June 30, 2021
3 Source, Galaxy Digital Finance, as of August 31, 2021

About Invesco Ltd.
Invesco Ltd. is a global independent investment management firm dedicated to delivering an investment experience that helps people get more out of life. Our distinctive investment teams deliver a comprehensive range of active, passive and alternative investment capabilities. With offices in more than 20 countries, Invesco managed $1.5 trillion in assets on behalf of clients worldwide as of June 30, 2021. For more information, visit www.invesco.com.

Invesco Ltd. Media Contact: Stephanie Diiorio, [email protected], (212) 278-9037

About Galaxy Digital
Galaxy Digital is a diversified financial services and investment management company in the digital asset, cryptocurrency, and blockchain technology sectors. Galaxy Digital’s team has extensive experience spanning investing, portfolio management, capital markets, venture capital, asset management, and blockchain technology. Galaxy Digital operates in the following businesses: Trading, Asset Management, Principal Investments, Investment Banking, and Mining. Galaxy Digital’s CEO and Founder is Mike Novogratz. The Company is headquartered in New York City, with offices in Chicago, San Francisco, London, Amsterdam, Tokyo, Hong Kong, the Cayman Islands (registered office), and New Jersey.

Disclaimers

The TSX has neither approved nor disapproved the contents of this press release.

SOURCE Galaxy Digital Holdings Ltd.

Galaxy Digital Contacts for further information:
Investors Relations Contacts:
Elsa Ballard, [email protected], (212) 390-9216
Steven Wald, [email protected], (212) 390-9216
Media Relations Contact: Eva Casanova, [email protected], (917) 847-4796

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/invesco-etfs-and-galaxy-digital-partner-to-offer-investors-exposure-to-an-expansive-range-of-products-in-the-digital-asset-ecosystem-301382506.html

SOURCE Invesco Ltd.

Intrado Introduces New HouseCalls Pro Capabilities to Help Health Systems Seamlessly Engage with Patients

Leading digital patient engagement platform now offers referral management among its many automated workflows and integrates with Cerner and Meditech EHR systems

ISLANDIA, N.Y., Sept. 22, 2021 (GLOBE NEWSWIRE) — Intrado Corporation (“Intrado” or the “Company”), a global technology-enabled services company, today unveiled new capabilities within HouseCalls Pro, its digital patient engagement platform. HouseCalls Pro automates workflows and fosters true two-way communication between patients and health systems, creating a superior healthcare experience for patients and improving long-term outcomes.

HouseCalls Pro’s new automated referral management capability improves referral closure rates and care coordination for patients that require treatment by a specialist. Instead of staff calls to patients ending up in voicemail, patients are contacted via text messaging (SMS) for scheduling. Based on their response, the patient can self-schedule the appointment via SMS or be connected, in real time, to the referred department.

“HouseCalls Pro gave us the ability to efficiently reach out to 6,000 patients via text and allow them to self-schedule their COVID-19 vaccination appointments quickly while saving more than 500 call center staff hours. It also significantly reduced our no-show rate to just one percent, which meant more patients got vaccinated, improving public health for all,” said Nathanael Kempff, Integration Architect at Confluence Health, a Washington State-based health system.

With the addition of SMS-based referral management, HouseCalls Pro is creating more opportunities for healthcare organizations to connect with patients, including:

  • appointment self-scheduling,
  • appointment reminders,
  • automated recall for wellness and preventative care,
  • health education,
  • pre- and post-procedure instructions,
  • account balance notifications, and
  • vaccination outreach.

“We worked with Intrado HouseCalls Pro to develop a new automated referrals workflow,” shared Jessica Boutain, Senior Application Analyst, Froedtert & The Medical College of Wisconsin. “We are pleased to share that within a few weeks we expanded the initial deployment of three specialties to 30 specialties. We’re engaging more patients more efficiently, which is helping us achieve patient health and resource goals.”

A Media Snippet accompanying this announcement is available by clicking on the image or link below

Intrado Healthcare HouseCalls Pro New Capabilities: Intrado Healthcare HouseCalls Pro New Capabilities

Other new capabilities include deep integration with Cerner and Meditech electronic health record (“EHR”) systems without the complex Health Level Seven International (HL7) interfaces required by other solutions. The platform triggers communications from, and writes responses back to, the EHR. As a result, hospitals and health systems can leverage existing IT investments to automate patient engagement, saving time and money. HouseCalls Pro already offers such integration with Epic, Athenahealth, and NextGen.

“The HouseCalls Pro platform leverages EHR systems to free clinicians and support staff from onerous manual tasks and phone-based communications so they can spend more time focusing on patient care. That’s a win for patients, staff, and health systems alike,” said Vik Krishnan, General Manager of Intrado Digital Workflows.

These unique features and benefits explain why 100 percent of users surveyed by KLAS said they would purchase HouseCalls Pro again. For more information about HouseCalls Pro, please visit: intrado.com/healthcare.

About Intrado Corporation

Intrado Corporation is an innovative, cloud-based, global technology partner to clients around the world. Our solutions connect people and organizations at the right time and in the right ways, making those mission-critical connections more relevant, engaging, and actionable – turning Information to Insight.

Intrado has sales and/or operations in the United States, Canada, Europe, the Middle East, Asia Pacific, Latin America, and South America. Intrado is controlled by affiliates of certain funds managed by Apollo Global Management, Inc. (NYSE: APO). For more information, please call 1-800-841-9000 or visit www.intrado.com.

Contacts

Dave Pleiss                                                       
Investor and Public Relations                                
[email protected]                                       
402.716.6578



BriaCell Announces TSXV Acceptance of Normal Course Issuer Bid

BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 22, 2021 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, today announces that the TSX Venture Exchange (the “TSXV”) has accepted the Company’s Notice of Intention to implement a normal course issuer bid (the “Buyback”).

Pursuant to the Buyback, the Company may, during the 12-month period commencing on September 28, 2021 and ending September 27, 2022 purchase, through the facilities of the TSXV or The Nasdaq Capital Market (“Nasdaq”) or alternative exchanges, (i) up to 1,341,515 common shares (the “Common Shares”) and (ii) up to 411,962 publicly traded BCTXW warrants (the “Listed Warrants”) in total, representing 10% of the 13,415,154 Common Shares and 10% of the 4,119,622 Listed Warrants, respectively, that comprise the “public float” as of September 21, 2021. Independent Trading Group (ITG) Inc. will act as the Company’s advisor and dealer manager in respect of the Buyback. The Buyback will in no way interfere with BriaCell’s ambitious growth plans to expand into previously-announced areas of cancer immunotherapy and/or advance its current breast cancer clinical trials.

A copy of the Form 5G – Notice of Intention to make a Normal Course Issuer Bid filed by the Company with the TSXV can be obtained from the Company upon request without charge.

BriaCell’s proposed repurchases may be conducted through open market transactions at prevailing market prices, in privately negotiated transactions, in block trades, and/or through other legally permissible means, subject to the market conditions and in compliance with applicable rules and regulations. The timing and dollar amount of repurchase transactions will be subject to the Securities and Exchange Commission (the “SEC”) Rule 10b-18 and/or Rule 10b5-1 requirements. Purchases of Common Shares or Listed Warrants through the Nasdaq will not, during the 12-month period, exceed 5% of the outstanding Common Shares or Listed Warrants in the aggregate and as of the commencement of the Buyback. BriaCell’s Board of Directors will be reviewing the program periodically and may revise the terms and/or size or suspend or discontinue the program.

About BriaCell Therapeutics Corp.

BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer. More information is available at https://briacell.com/.

Safe Harbor

This press release contains “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on BriaCell’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully under the heading “Risks and Uncertainties” in the Company’s most recent Management’s Discussion and Analysis, under “Risks and Uncertainties” in the Company’s other filings with the Canadian securities regulatory authorities and the U.S. Securities and Exchange Commission, all of which are available under our profiles on SEDAR at www.sedar.com and on EDGAR at www.sec.gov. Forward-looking statements contained in this announcement are made as of this date, and BriaCell Therapeutics Corp. undertakes no duty to update such information except as required under applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

Company Contact:

William V. Williams, MD
President & CEO
1-888-485-6340
[email protected]

Media Relations:

Jules Abraham
Director of Public Relations
CORE IR
917-885-7378
[email protected]

Investor Relations Contact:

CORE IR
[email protected]



Broadcom Introduces World’s Lowest Power L1/L5 GNSS Receiver for Mobile and Wearable Applications

Third generation dual-frequency GNSS receiver features advanced multipath mitigation, L5 acquisition capability, LTE filtering, and jamming protection

SAN JOSE, Calif., Sept. 22, 2021 (GLOBE NEWSWIRE) — Broadcom Inc. (NASDAQ: AVGO) today announced the world’s lowest power L1/L5 GNSS receiver chip, the BCM4778, optimized for mobile and wearable applications. Equipped with the latest GNSS innovations, this third-generation chip is 35% smaller and consumes 5 times less power than the previous generation.

Dual-frequency GNSS continues to be an important location feature for modern mobile and wearable devices as it provides greater positioning accuracy for location-based services (LBS) applications. The advanced L5 signal enables sidewalk-level accuracy for pedestrian navigation in urban environments, as well as lane-level accuracy for vehicle navigation.

Reduction in GNSS power consumption is crucial to extending the battery life of a mobile or wearable device. Compared to GNSS receivers used in integrated platforms, Broadcom’s single-chip BCM4778 delivers significantly lower power consumption and higher performance while offering more advanced GNSS features, such as the next-generation Grid Tracking™ urban multipath mitigation technology. Further, the BCM4778 increases the GNSS always-on battery lifetime on a smart watch by 30 hours when compared to the previous generation chip operating on a 300mAh battery. The extended battery life benefit helps drive new experiences in smart watches and phones. For example, smart watches can keep the GNSS always-on for fitness applications for multiple days on a single battery charge.

In addition, the BCM4778 features fully integrated LNAs for L1 and L5 bands, which reduces RF front-end BOM costs and footprint requirements, ideal for space-constrained applications. The chip offers immense flexibility to smart watch and phone designers with its small size. Having the ability to place the BCM4778 closer to the antenna helps improve signal reception and thereby enhance the overall GNSS performance.

Product Highlights

  • 7nm CMOS technology
  • Typical power consumption
    • 4mW L1 band only
    • 6mW L1+L5 simultaneous
  • FCBGA package
  • New Grid Tracking™ technology
    • Advanced multipath mitigation
    • Continuously tracks the full L5 channel
  • Capable of L5 acquisition
    • Increased processing capability and throughput
  • Advanced LTE filtering and jamming mitigation
    • Enhanced LTE Band 13 and Band 14 filtering
    • Spoofing and jamming detector
    • Jamming mitigation through multiband and multi constellation
  • Reduced BOM cost and footprint
    • Flexibility in using internal LNAs
    • Optional operation without interstage SAW filters
    • Integrated switching regulator with direct connect to battery

“With the launch of this third generation dual-frequency GNSS receiver chip, Broadcom continues the tradition of raising the bar for mobile GNSS,” said Vijay Nagarajan, vice president of marketing for the Wireless Communications and Connectivity Division at Broadcom. “Always-on dual frequency GNSS is a key request from mobile and wearable OEMs, and we are thrilled to deliver it.”

“We are excited to see this impressive power reduction, combined with the L5 Grid Tracking technology in the new Broadcom GNSS chip. This will increase the impact of Google’s 3DMA ray-tracing for urban multipath mitigation,” said Frank van Diggelen, principal software engineer at Google.

“Consumer electronic companies have been faced with the challenge of managing power consumption versus performance, often having to choose one over the other. Broadcom’s innovative approach to the BCM4778 allows their customers to realize improvements on both fronts,” said Ramon T. Llamas, research director for mobile devices at IDC. “The result: device manufacturers can enable new experiences and run applications over a sustained period of time. In addition, by reducing its BOM cost and its physical footprint, Broadcom is enabling further benefits from cost savings and design configurability.”

Availability

Broadcom is currently sampling the BCM4778 to its early access partners and customers. Please contact your local Broadcom sales representative for samples and pricing.

More information on Broadcom’s BCM4778 product is available online at:

https://www.broadcom.com/products/wireless/gnss-gps-socs/bcm4778

Additionally, Broadcom will be presenting further information on the chip in the Session B5, Panel: GNSS Chipset Technology – Trends, Opportunities and Challenges panel at the ION GNSS+ 2021 on September 24th.

About Broadcom

Broadcom Inc. (NASDAQ: AVGO) is a global technology leader that designs, develops and supplies a broad range of semiconductor and infrastructure software solutions. Broadcom’s category-leading product portfolio serves critical markets including data center, networking, enterprise software, broadband, wireless, storage and industrial. Our solutions include data center networking and storage, enterprise, mainframe and cyber security software focused on automation, monitoring and security, smartphone components, telecoms and factory automation. For more information, go to https://www.broadcom.com.

Broadcom, the pulse logo, and Connecting everything are among the trademarks of Broadcom. The term “Broadcom” refers to Broadcom Inc., and/or its subsidiaries. Other trademarks are the property of their respective owners.

Press Contact:
Khanh Lam
Corporate Communications
[email protected]
Telephone: +1 408 433 8649



Castor Maritime Inc. Announces New Charter Agreements and Delivery of the M/V Magic Mars

LIMASSOL, Cyprus, Sept. 22, 2021 (GLOBE NEWSWIRE) — Castor Maritime Inc. (NASDAQ: CTRM), (“Castor”, or the “Company”), a diversified global shipping company, announces that on September 20, 2021, it took delivery of M/V Magic Mars, the 2014 Korean-built Panamax dry bulk carrier it had agreed to acquire as previously announced on May 17, 2021. The vessel acquisition was financed in its entirety with cash on hand.

M/V Magic Mars has been fixed on a time charter contract at a gross daily charter rate of $34,600. The charter is expected to commence on or around September 24, 2021, and will have a duration of about 75 days.

The Company also announces that M/V Magic Argo, a 2009 built Kamsarmax dry bulk carrier, has been fixed on a time charter contract at a gross daily charter rate of $33,500. The charter commenced on September 14, 2021, and has a duration of about 90 days.

Mr. Petros Panagiotidis, Chief Executive Officer of Castor commented:

“We continue to see strong demand for dry bulk transportation services, as evidenced by our recent employment fixtures at attractive gross daily charter rates.

Our well-timed expansion plans in early 2021 and persistent focus on prompt deliveries of acquired vessels, allow our Company to take advantage of this strong market with a dry bulk fleet consisting of 19 vessels on a fully delivered basis.”


About Castor Maritime Inc.

Castor Maritime Inc. is an international provider of shipping transportation services through its ownership of oceangoing cargo vessels.

On a fully delivered basis, Castor will own a fleet of 27 vessels, with an aggregate capacity of 2.3 million dwt, consisting of 1 Capesize, 7 Kamsarmax and 11 Panamax dry bulk vessels, as well as 1 Aframax, 5 Aframax/LR2 and 2 MR1 tankers. Where we refer to information on a “fully delivered basis”, we are referring to such information after giving effect to the successful consummation of our recent vessel acquisitions.

For more information please visit the Company’s website at www.castormaritime.com. Information on our website does not constitute a part of this press release.


Cautionary Statement Regarding Forward-Looking Statements

Matters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements, which are other than statements of historical facts. We desire to take advantage of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are including this cautionary statement in connection with this safe harbor legislation. The words “believe”, “anticipate”, “intend”, “estimate”, “forecast”, “project”, “plan”, “potential”, “will”, “may”, “should”, “expect”, “pending” and similar expressions identify forward-looking statements. The forward-looking statements in this press release are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, our management’s examination of historical operating trends, data contained in our records and other data available from third parties. Although we believe that these assumptions were reasonable when made, because these assumptions are inherently subject to significant uncertainties and contingencies which are difficult or impossible to predict and are beyond our control, we cannot assure you that we will achieve or accomplish these expectations, beliefs or projections. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. In addition to these important factors, other important factors that, in our view, could cause actual results to differ materially from those discussed in the forward-looking statements include general dry bulk and tanker shipping market conditions, including fluctuations in charter hire rates and vessel values, the strength of world economies the stability of Europe and the Euro, fluctuations in interest rates and foreign exchange rates, changes in demand in the dry bulk and tanker shipping industry, including the market for our vessels, changes in our operating expenses, including bunker prices, dry docking and insurance costs, changes in governmental rules and regulations or actions taken by regulatory authorities, potential liability from pending or future litigation, general domestic and international political conditions, potential disruption of shipping routes due to accidents or political events, the length and severity of the COVID-19 outbreak, the impact of public health threats and outbreaks of other highly communicable diseases, the impact of the expected discontinuance of LIBOR after 2021 on interest rates of our debt that reference LIBOR, the availability of financing and refinancing and grow our business, vessel breakdowns and instances of off-hire, potential exposure or loss from investment in derivative instruments, potential conflicts of interest involving our Chief Executive Officer, his family and other members of our senior management, and our ability to complete acquisition transactions as planned. Please see our filings with the Securities and Exchange Commission for a more complete discussion of these and other risks and uncertainties. The information set forth herein speaks only as of the date hereof, and we disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this communication.


CONTACT DETAILS

For further information please contact:

Petros Panagiotidis
Castor Maritime Inc.
Email: [email protected]

Media Contact:
Kevin Karlis
Capital Link
Email: [email protected]



Seventy-Four Percent of Organizations Attribute Damaging Cyberattacks to Vulnerabilities in Technology Put in Place During the Pandemic, According to Global Industry Study

Eighty percent of security and business leaders said their organizations have more exposure to risk today as a result of remote work

COLUMBIA, Md., Sept. 22, 2021 (GLOBE NEWSWIRE) — Tenable®, Inc., the Cyber Exposure company, published a global industry study that revealed 74% of organizations attribute recent business-impacting* cyberattacks to vulnerabilities in technology put in place during the pandemic. The data is drawn from ‘Beyond Boundaries: The Future of Cybersecurity in the New World of Work,’ a commissioned study of more than 1,300 security leaders, business executives and remote employees conducted by Forrester Consulting on behalf of Tenable.

From cloud services and applications to personal devices and remote access tools, the corporate attack surface exploded in record time. Difficulty managing the plethora of technologies has made enterprises more vulnerable and propelled cyberattacks. Moreover, 80% of security and business leaders said their organizations are more exposed to risk as a result of remote work. This exposure was largely driven by three factors:

Enabling a workforce without boundaries: Over half of remote workers access customer data using a personal device, yet 71% of security leaders lack high or complete visibility into remote employee home networks. This gap is well understood by bad actors, as reflected in the fact that 67% percent of business-impacting cyberattacks targeted remote employees.

Expanding the software supply chain: 65% of security and business leaders attribute recent cyberattacks to a third-party software compromise; 61% report increased risk due to their expanded software supply chain.

Migrating to the cloud: 80% of security and business leaders believe moving business-critical functions to the cloud elevated their risk; 62% of organizations suffered business-impacting attacks involving cloud assets.

“Remote and hybrid work strategies are here to stay and so will the risks they introduce unless organizations get a handle on what their new attack surface looks like,” said Amit Yoran, CEO, Tenable. “This study reveals two paths forward — one riddled with unmanaged risk and unrelenting cyberattacks and another that accelerates business productivity and operations in a secure way. CISOs and CEOs have the opportunity and responsibility to securely harness the power of technology and manage cyber risk for the new world of work.”

Hybrid work models and a digital-first economy have brought cybersecurity front and center as a critical investment that can make or break short- and long-term business strategies. To address this demand, two thirds or more of security leaders plan to increase their cybersecurity investments over the next 12 to 24 months, with roughly three-quarters planning to spend more on vulnerability management and cloud security. What’s more, understanding the profound risks created by talent shortages, 64% of leaders lacking staff plan to invest within by increasing their teams’ headcount over the next 12 months.

To read the full study, visit https://www.tenable.com/analyst-research/forrester-cyber-risk-report-2021.

Note to Editors:

  • Forrester Consulting conducted an online survey of 426 security leaders, 422 business executives, and 479 remote workers (i.e., full-time employees working three or more days from home), as well as six telephonic interviews with business and security executives, to explore shifts in cybersecurity strategies at large enterprises made in response to the pandemic. The study was fielded in Australia, Brazil, France, Germany, India, Japan, Mexico, Saudi Arabia, the U.K. and the U.S. in April 2021.
  • *“Business-impacting” relates to a cyberattack or compromise that results in one or more of the following outcomes: a loss of customer, employee, or other confidential data; interruption of day-to-day operations; ransomware payout; financial loss or theft; and/or theft of intellectual property.

About Tenable
Tenable®, Inc. is the Cyber Exposure company. Over 30,000 organizations around the globe rely on Tenable to understand and reduce cyber risk. As the creator of Nessus®, Tenable extended its expertise in vulnerabilities to deliver the world’s first platform to see and secure any digital asset on any computing platform. Tenable customers include more than 50 percent of the Fortune 500, more than 30 percent of the Global 2000 and large government agencies. Learn more at www.tenable.com.

Contact Information:

Cayla Baker
Tenable
[email protected]
443-545-2102, x 1544